A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

NCT06565195 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: LY3962681
OTHER: Placebo (aCSF)

Sponsor

Prevail Therapeutics